FDA Import Refusal SCS-4197260-1/10003/1 — DAESUNG MEDI
The FDA refused shipment SCS-4197260-1/10003/1 from DAESUNG MEDI (South Korea) on Jan 20, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jan 20, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PDZ05 ONABOTULINUMTOXINA
- Charges
- 118,3280,75